Total Funding
89
72
Total FundingSeed raised
Growth Score
-2 pts
Heat Score
-3 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
73719
Amprologix Ltd is a world-leading biotechnology and synthetic biology company Ingenza.
About the Company
Amprologix has been established to develop the work of Professor Mathew Upton. The company aims to introduce new classes of antibiotics to help tackle the threat of antimicrobial resistance. The first product from the company is expected to be a cream containing epidermicin, which can rapidly kill harmful bacteria, including MRSA, Streptococcus and
Entercoccus at very low doses. Amprologix has already secured industry involvement through a partnership with world-leading biotechnology and synthetic biology company Ingenza.
